Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses.
Hantaviruses cause two human diseases: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Hantaviruses infect human endothelial cells but cause little or no damage to the infected endothelium. We analyzed with Affymetrix DNA Arrays (Santa Clara, CA) the endothelial cell transcriptional responses directed by hantaviruses associated with HPS [New York-1 virus (NY-1V)], HFRS [Hantaan virus (HTNV)], or by a hantavirus not associated with human disease [Prospect Hill virus (PHV)]. Hantavirus infections induced 117 cellular genes and repressed 25 genes by >3-fold, 4 days postinfection (p.i.). Although >80% of cells were infected by each virus 1 day p.i., PHV induced or repressed 67 genes at this early time compared with three genes altered by HTNV or NY-1V. The early high-level induction of 24 IFN-stimulated genes by PHV (4- to 229-fold) represents a fundamental difference in the temporal regulation of cellular responses by pathogenic and nonpathogenic hantaviruses. Because all hantaviruses induced >23 IFN-stimulated genes at late times p.i., pathogenic hantaviruses appear to suppress early cellular IFN responses that are activated by nonpathogenic hantaviruses. At late times p.i., 13 genes were commonly induced by HTNV and NY-1V that were not induced by PHV. In contrast to NY-1V, HTNV uniquely induced a variety of chemokines and cell adhesion molecules (i.e., IL-8, IL-6, GRO-beta, ICAM), as well as two complement cascade-associated factors that may contribute to immune components of HFRS disease. NY-1V failed to induce most cellular chemokines directed by HTNV (3/14) or genes primarily activated by NF-kappaB. However, NY-1V uniquely induced beta3 integrin-linked potassium channels, which could play a role in HPS-associated vascular permeability. These studies provide a basic understanding of hantavirus-directed cellular responses that are likely to differentiate pathogenic and nonpathogenic hantaviruses, contribute to HFRS and HPS pathogenesis, and provide insight into disease mechanisms and potential therapeutic interventions.
D000818:Animals; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D003165:Complement System Proteins / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000821:virology*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D018063:Hantaan virus / Q000472:pathogenicity; D006476:Orthohantavirus / Q000472:pathogenicity*; D018804:Hantavirus Pulmonary Syndrome / Q000209:etiology / Q000235:genetics / Q000821:virology; D006480:Hemorrhagic Fever with Renal Syndrome / Q000209:etiology / Q000235:genetics / Q000821:virology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D011956:Receptors, Cell Surface / Q000235:genetics; D055293:Receptors, Urokinase Plasminogen Activator; D040262:Receptors, Vascular Endothelial Growth Factor / Q000235:genetics; D014709:Vero Cells; D014774:Virulence
D018836:Inflammation Mediators; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D003165:Complement System Proteins; D040262:Receptors, Vascular Endothelial Growth Factor